Myelodysplastic Syndrome Clinical Trial

Pathogenesis of Hematologic Malignancies

Summary

The cause of blood and bone marrow cancers is poorly understood; however, most research focuses on how cancer cells grow and develop. Because the causes of these cancers are unknown, current treatments may be unnecessarily harsh and often do not provide a cure. Identifying the causes of blood cancers would allow for the development of treatments that are more likely to provide a cure. To find the causes of blood and bone marrow cancers, we will look for specific cancer cell abnormalities that are responsible for cancer cell growth. We will then look to see if drugs that can reverse these abnormalities can kill cancer cells.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Suspected or confirmed diagnosis of AL, LPD, MDS, or MPD
Male or female of all ages
Willing and able to sign informed consent
Willing guardian consent for participants under 18 years of age

Exclusion Criteria:

No suspected or confirmed diagnosis of acute leukemias (AL), lymphoproliferative disorders (LPD), myelodysplastic syndromes (MDS), or myeloproliferative diseases (MPD)

Study is for people with:

Myelodysplastic Syndrome

Estimated Enrollment:

5000

Study ID:

NCT01728402

Recruitment Status:

Enrolling by invitation

Sponsor:

OHSU Knight Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

OHSU Knight Cancer Institute
Portland Oregon, 97239, United States

How clear is this clinincal trial information?

Study is for people with:

Myelodysplastic Syndrome

Estimated Enrollment:

5000

Study ID:

NCT01728402

Recruitment Status:

Enrolling by invitation

Sponsor:


OHSU Knight Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.